Search

everythinglearnresearchcommunity

for

Search:↓

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Polycystic Ovary Syndrome (PCOS) affects Iranian women's feelings of femininity and self-image.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

Different types of PCOS need specific diagnosis methods and treatments.

Spironolactone plus finasteride reduces hirsutism more effectively.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Menopause affects hair and skin; more research needed for treatment.